journal article·2026-07-10Open access

Mechanical Flexibility Enables DNA Origami to Overcome Steric Confinement in Mucus

Matteo Tollemeto, Emily Tsang, Marie Karen Tracy Hong Lin, Luca Mannino, Kurt V. Gothelf, Anja Boisen

Abstract

ABSTRACT Size exclusion within biological hydrogels imposes a fundamental constraint on the design of nanocarriers, limiting the transport of cargo‐loaded and structurally complex materials through mucus barriers. While surface passivation strategies are commonly used to improve compatibility, they do not address steric limitations imposed by the polymer network. Here, we introduce mechanical flexibility as an independent materials design parameter to expand the functional transport window of nanocarriers in mucus. Using programmable DNA origami to decouple flexibility from size and surface chemistry, we show that increased structural compliance enhances transport under steric confinement by facilitating passage through confined network pores. When surface‐driven aggregation dominates, passivation is required to restore transport, after which flexibility provides additional gains. Together, these results establish mechanical flexibility as a general materials design strategy for improving transport under size‐constrained conditions, with implications for nanocarrier engineering across biological barriers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced biosensing and bioanalysis techniques · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Health Technology Technical University of Denmark Kongens Lyngby Denmark

Department of Biological Engineering Massachusetts Institute of Technology Cambridge Massachusetts USA

Department of Chemistry and Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus C Denmark

National Centre for Nano Fabrication and Characterization Technical University of Denmark Kongens Lyngby Denmark

Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE) Faculty of Medicine and Health Technology Tampere University Tampere Finland

Funding

Danmarks Grundforskningsfond · Villum Fonden · Novo Nordisk Fonden

References (37)

Show source-provided references
1. 10.1016/j.addr.2008.11.00210.1016/j.addr.2008.11.002 ↗
2. The Role of Mucus as an Invisible Cloak to Transepithelial Drug Delivery by Nanoparticles10.1016/j.addr.2017.11.002 ↗
3. 10.1073/pnas.060861110410.1073/pnas.0608611104 ↗
4. 10.1021/acs.biomac.6b0016410.1021/acs.biomac.6b00164 ↗
5. 10.1021/acs.nanolett.6b0351510.1021/acs.nanolett.6b03515 ↗
6. 10.1016/j.jconrel.2019.06.01510.1016/j.jconrel.2019.06.015 ↗
7. 10.1021/acsnano.2c1114710.1021/acsnano.2c11147 ↗
8. 10.1021/acs.nanolett.5c0248710.1021/acs.nanolett.5c02487 ↗
9. 10.1016/j.addr.2008.09.00810.1016/j.addr.2008.09.008 ↗
10. Mucus as a Barrier to Drug Delivery – Understanding and Mimicking the Barrier Properties10.1111/bcpt.12342 ↗
11. Property Profiling of Biosimilar Mucus in a Novel Mucus‐Containing in Vitro Model for Assessment of Intestinal Drug Absorption10.1016/j.ejpb.2014.01.001 ↗
12. Evaluation of Drug Permeation Under Fed state Conditions Using Mucus‐Covered Caco‐2 Cell Epithelium10.1016/j.ejps.2018.02.032 ↗
13. 10.1016/j.ejpb.2021.10.00810.1016/j.ejpb.2021.10.008 ↗
14. 10.1073/pnas.140886911210.1073/pnas.1408869112 ↗
15. 10.1038/s41467‐017‐02127‐610.1038/s41467‐017‐02127‐6 ↗
16. 10.1038/nature0458610.1038/nature04586 ↗
17. 10.1093/nar/gkp43610.1093/nar/gkp436 ↗
18. 10.1021/nn405408g10.1021/nn405408g ↗
19. 10.1126/science.aah597410.1126/science.aah5974 ↗
20. 10.1016/j.jconrel.2025.11426810.1016/j.jconrel.2025.114268 ↗
21. 10.1021/acs.nanolett.9b0484110.1021/acs.nanolett.9b04841 ↗
22. 10.1038/nmeth.157010.1038/nmeth.1570 ↗
23. 10.1093/nar/gkr117310.1093/nar/gkr1173 ↗
24. 10.1039/C8SM01834K10.1039/C8SM01834K ↗
25. 10.1021/acs.nanolett.5c0235210.1021/acs.nanolett.5c02352 ↗
26. 10.1002/sstr.7037310.1002/sstr.70373 ↗
27. 10.1021/acsnano.4c0176010.1021/acsnano.4c01760 ↗
28. Mimicking Regional and Fasted/Fed State Conditions in the Intestine With the Mucus‐PVPA In Vitro Model: The Impact of pH and Simulated Intestinal Fluids on Drug Permeability10.1016/j.ejps.2019.02.035 ↗
29. 10.1016/j.ijpharm.2024.12473310.1016/j.ijpharm.2024.124733 ↗
30. Hydrophobic Drug Particles Adopt a Complex Biomolecular Corona in Ex Vivo Gastrointestinal Fluids10.1016/j.jconrel.2025.114354 ↗
31. Colloidal Interactions in Simulated Intestinal Fluids: Implications for Oral Drug Delivery at the Nanoscale10.1002/smsc.202500350 ↗
32. 10.1002/jps.2150210.1002/jps.21502 ↗
33. Exploring Drug Solubility in Fasted Human Intestinal Fluid Aspirates: Impact of Inter‐Individual Variability, Sampling Site and Dilution10.1016/j.ijpharm.2017.05.072 ↗
34. 10.1002/anie.20080352610.1002/anie.200803526 ↗
35. 10.1021/acsnano.5b0002810.1021/acsnano.5b00028 ↗
36. 10.1002/smll.20240250210.1002/smll.202402502 ↗
37. R.Mestre (2022) https://doi.org/10.5281/zenodo.5905486.